Philips (NYSE:PHG) has issued corrections for some of its Trilogy Evo ventilator platforms due to multiple issues.

ProSomnus announced today that it received FDA 510(k) clearance for its RPMO₂ obstructive sleep apnea (OSA) therapy device.

This guide breaks down what separates enterprise-grade HME/DME billing platforms from glorified spreadsheets, which features actually move the needle on reimbursement rates, and how to evaluate ...